Abstract
Primary ovarian insufficiency (POI) is not only a gynecological problem but also has serious effects on women’s health such as changes in hormone levels that can trigger fluctuations in blood sugar level and inflammation status. The present study was designed to determine vitamin D, copper, zinc, metabolic parameters [insulin, homeostasis model of assessment-insulin resistance (HOMA-IR)], inflammation parameters such as procalcitonin and high sensitivity C reactive protein (hs-CRP), and lipid profile in POI patients and control subjects with normal menstrual cycles. A total of 43 patients with nondiabetic POI were studied in order to evaluate and compare the findings with those of the control group, which comprised 33 women with normal menstrual cycles. The women with POI had higher levels of serum copper, serum insulin, glucose, LDL-cholesterol, total cholesterol, HOMA-IR, hs-CRP, and procalcitonin, whereas serum vitamin D and zinc levels were lower compared with the healthy control group. Follicle-stimulating hormone (FSH) levels were positively correlated with insulin, glucose, HOMA-IR, hs-CRP, procalcitonin, and copper and negatively correlated with vitamin D and zinc levels. In multivariate statistic analyses with body mass index and FSH as dependent variables, FSH was positively associated with copper and HOMA-IR negatively with vitamin D levels. The present study demonstrated that women with POI have traditional risk factors for diabetes mellitus, including lower levels of vitamin D, whereas higher levels of copper and HOMA-IR.
Similar content being viewed by others
References
Kalu E, Panay N (2008) Spontaneous premature ovarian failure: management challenges. Gynecol Endocrinol 24:273–279
Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N (2003) Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 18:199–206
Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA (2010) Premature menopause or early menopause: long-term health consequences. Maturitas 65(2):161–166
Andersson B (2000) Hormone replacement therapy in postmenopausal women with diabetes mellitus: a risk-benefit assessment. Drugs Aging 17(5):399–410
Szmuilowicz ED, Stuenkel CA, Seely EW (2009) Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol 5(10):553–558
Espeland MA, Hogan PE, Fineberg SE, Howard G, Schrott H, Waclawiw MA, Bush TL (1998) Effect of postmenopausal hormone therapy on glucose and insulin concentrations: PEPI Investigators. Postmenopausal Oestrogen/Progestin Interventions Diabetes Care 21:1589–1595
Gabal LL, Goodman-Gruen D, Barrett-Connor E (1997) The effect of postmenopausal oestrogen therapy on the risk of non-insulin-dependent diabetes mellitus. Am J Public Health 87:443–445
Donahue RP, Bean JA, Donahue RA, Goldberg RB, Prineas RJ (1997) Insulin response in a triethnic population: effects of sex, ethnic origin, and body fat. Miami Community Health Study. Diabetes Care 20:1670–1676
Straub RH (2007) The complex role of oestrogens in inflammation. Endocr Rev 28:521–574
Davison S, Davis SR (2003) New markers for cardiovascular disease risk in women: impact of endogenous oestrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 88:2470–2478
Stubbins RE, Najjar K, Holcomb VB, Hong J, Núñez NP (2012) Ooestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes Obes Metab 14(1):58–66
Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116:1793–1801
Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321:199–204
Abbasi A, Corpeleijn E, Postmus D, Gansevoort RT, de Jong PE, Gans RO, Struck J, Hillege HL, Stolk RP, Navis G, Bakker SJ (2011) Plasma procalcitonin and risk of type 2 diabetes in the general population. Diabetologia 54(9):2463–2465
Naziroğlu M, Butterworth PJ (2005) Protective effects of moderate exercise with dietary vitamin C and E on blood antioxidative defense mechanism in rats with streptozotocin-induced diabetes. Can J Appl Physiol 30(2):172–185
Song YJ, Wang XK, Li Y et al (2005) Zinc and the diabetic heart. Biometals 18:325–332
Partida-Hernández G, Arreola F, Fenton B et al (2006) Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients. Biomed Pharmacother 60:161–168
Chausmer AB (1998) Zinc, insulin and diabetes. J Am Coll Nutr 17:109–115
Michos C, Kalfakakou V, Karkabounas S, Kiortsis D, Evangelou A (2010) Changes in copper and zinc plasma concentrations during the normal menstrual cycle in women. Gynecol Endocrinol 26(4):250–255
Kechrid Z, Hamdi M, Naziroğlu M, Flores-Arce M (2012) Vitamin D supplementation modulates blood and tissue zinc, liver glutathione and blood biochemical parameters in diabetic rats on a zinc-deficient diet. Biol Trace Elem Res 148(3):371–377
Mezza T, Muscogiuri G, Sorice GP, Prioletta A, Salomone E, Pontecorvi A, Giaccari A (2012) Vitamin D deficiency: a new risk factor for type 2 diabetes? Ann Nutr Metab 61(4):337–348
Kayan M, Nazıroğlu M, Barak C (2010) Effects of vitamin C and E combination on trace element levels in blood of smokers and nonsmokers radiology X-ray technicians. Biol Trace Elem Res 136(2):140–148
Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K (2001) Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J 48:81–86
Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health Mayo. Clin Proc 81:353–373
Thomas GN, Scragg R, Jiang CQ, Chan W, Marz W, Pilz S, Kim HC, Tomlinson B, Bosch J, Lam TH, Cheung BM, Cheng KK (2012) Hyperglycaemia and vitamin D: a systematic overview. Curr Diabetes Rev 8(1):18–31
Hyppönen E, Berry D, Cortina-Borja M, Power C (2010) 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. PLoS One 5(5):e10801
Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD (2010) Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am J Med 123(4):335–341
Chennaiah S, Vijayalakshmi V, Suresh C (2010) Effect of the supplementation of dietary rich phytooestrogens in altering the vitamin D levels in diet induced osteoporotic rat model. J Steroid Biochem Mol Biol 121(1–2):268–272
Jorde R, Sneve M, Torjesen PA, Figenschau Y, Gøransson LG, Omdal R (2010) No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 50:175–180
Hartiti S, Lopez-Aliaga I, Barrionuevo M et al (1994) Zinc metabolism in rats: effect of intestinal resection, cholecalciferol and ascorbic acid. Nutr Res 14(10):1523–1534
Blank M, Cohen J, Toder V, Shoenfeld Y (1991) Induction of antiphospholipid antibody syndrome in naBve mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 88:3069–3073
Gleicher N (1999) Reproductive failure prior to the onset of clinical autoimmune disease. Rheumatology (Oxford) 38:485–487
Hoek A, Schoemaker J, Drexhage HA (1997) Premature ovarian failure and ovarian autoimmunity. Endocr Rev 8:107–134
Özkaya MO, Nazıroğlu M, Barak C, Berkkanoglu M (2011) Effects of multivitamin/mineral supplementation on trace element levels in serum and follicular fluid of women undergoing in vitro fertilization (IVF). Biol Trace Elem Res 139(1):1–9
Sing RB, Niaz MA, Rastogi SS, Bajaj S et al (1998) Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 17:564–570
Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ (1982) Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 75:273–277
Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241–1248
Tanaka A, Kaneto H, Miyatsuka T, Yamamoto K, Yoshiuchi K, Yamasaki Y et al (2009) Role of copper ion in the pathogenesis of type 2 diabetes. Endocr J 56:699–706
Walter RM Jr, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CL (1991) Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 14(11):1050–1056
Prasad AS, Beck FW, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, Cardozo LJ (2007) Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 85:837–844
Guo CH, Liu PJ, Hsia S, Chuang CJ, Chen PC (2011) Role of certain trace minerals in oxidative stress, inflammation, CD4/CD8 lymphocyte ratios and lung function in asthmatic patients. Ann Clin Biochem 48(Pt 4):344–351
Dinarello CA (1984) Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 311:1413–1418
Bao B, Prasad AS, Beck FW, Fitzgerald JT, Snell D, Bao GW, Singh T, Cardozo LJ (2010) Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 91(6):1634–1641
Rossi L, Lombardo MF, Ciriolo MR, Rotilio G (2004) Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem Res 29(3):493–504
Bo S, Durazzo, Gambino R, Berutti C, Milanesio N, Caropreso A, Gentile L, Cassader M, Cavallo-Perin P, Pagano G (2008) Associations of dietary and serum copper with inflammation, oxidative stress, and metabolic variables in adults. J Nutr 138:305–310
Condomina J, Zornoza-Sabina T, Granero L, Polache A (2002) Kinetics of zinc transport in vitro in rat small intestine and colon: interaction with copper. Eur J Pharm Sci 16(4–5):289–295
Davis CD, Johnson WT (2001) Dietary copper and dimethylhydrazine affect protein kinase C isozyme protein and mRNA expression and the formation of aberrant crypts in colon of rats. Biofactors 15(1):11–26
Gower BA, Nagy TR, Goran MI, Toth MJ, Poehlman ET (1998) Fat distribution and plasma lipid–lipoprotein concentrations in pre-and postmenopausal women. Int J Obes Relat Metab Disord 22(7):605–611
Conflict of Interest
The authors report no declarations of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kulaksizoglu, M., Ipekci, S.H., Kebapcilar, L. et al. Risk Factors for Diabetes Mellitus in Women with Primary Ovarian Insufficiency. Biol Trace Elem Res 154, 313–320 (2013). https://doi.org/10.1007/s12011-013-9738-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-013-9738-0